Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases | European Heart Journal | 2013 | 1.6K |
Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the task force criteria | Circulation | 2010 | 1.3K |
Myocardial T1 mapping and extracellular volume quantification: a Society for Cardiovascular Magnetic Resonance (SCMR) and CMR Working Group of the European Society of Cardiology consensus statement | Journal of Cardiovascular Magnetic Resonance | 2013 | 684 |
Equilibrium contrast cardiovascular magnetic resonance for the measurement of diffuse myocardial fibrosis: preliminary validation in humans | Circulation | 2010 | 662 |
Frailty assessment in the cardiovascular care of older adults | Journal of the American College of Cardiology | 2014 | 608 |
Recommendations for interpretation of 12-lead electrocardiogram in the athlete | European Heart Journal | 2010 | 581 |
A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM risk-SCD) | European Heart Journal | 2014 | 570 |
Randomized trial of complete versus lesion-only revascularization in patients undergoing primary percutaneous coronary intervention for STEMI and multivessel disease: the CvLPRIT trial | Journal of the American College of Cardiology | 2015 | 479 |
Proposal for a revised definition of dilated cardiomyopathy, hypokinetic non-dilated cardiomyopathy, and its implications for clinical practice: a position statement of the ESC working group on myocardial and pericardial diseases | European Heart Journal | 2016 | 473 |
Left-dominant arrhythmogenic cardiomyopathy: an under-recognized clinical entity | Journal of the American College of Cardiology | 2008 | 467 |
Remote Ischemic Preconditioning and Outcomes of Cardiac Surgery | New England Journal of Medicine | 2015 | 465 |
2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation | Europace | 2018 | 461 |
Noncontrast T1 mapping for the diagnosis of cardiac amyloidosis | JACC: Cardiovascular Imaging | 2013 | 410 |
Clinical and genetic characterization of families with arrhythmogenic right ventricular dysplasia/cardiomyopathy provides novel insights into patterns of disease expression | Circulation | 2007 | 401 |
Evaluation of techniques for the quantification of myocardial scar of differing etiology using cardiac magnetic resonance | JACC: Cardiovascular Imaging | 2011 | 393 |
Percutaneous pulmonary valve implantation: impact of evolving technology and learning curve on clinical outcome | Circulation | 2008 | 367 |
Arrhythmogenic right ventricular cardiomyopathy type 5 is a fully penetrant, lethal arrhythmic disorder caused by a missense mutation in the TMEM43 gene | American Journal of Human Genetics | 2008 | 360 |
Safety and Efficacy of the Totally Subcutaneous Implantable Defibrillator: 2-Year Results From a Pooled Analysis of the IDE Study and EFFORTLESS Registry | Journal of the American College of Cardiology | 2015 | 353 |
Risk factors for malignant ventricular arrhythmias in lamin a/c mutation carriers a European cohort study | Journal of the American College of Cardiology | 2012 | 353 |
Management of grown up congenital heart disease | European Heart Journal | 2003 | 345 |
Natural history and familial characteristics of isolated left ventricular non-compaction | European Heart Journal | 2005 | 344 |
Worldwide experience with a totally subcutaneous implantable defibrillator: early results from the EFFORTLESS S-ICD Registry | European Heart Journal | 2014 | 336 |
Genetic counselling and testing in cardiomyopathies: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases | European Heart Journal | 2010 | 324 |
Prognostic Value of Late Gadolinium Enhancement Cardiovascular Magnetic Resonance in Cardiac Amyloidosis | Circulation | 2015 | 320 |
Identification and assessment of Anderson-Fabry disease by cardiovascular magnetic resonance noncontrast myocardial T1 mapping | Circulation: Cardiovascular Imaging | 2013 | 310 |